ICL Israel Chemicals (NYSE: ICL) released its third-quarter financial results, exceeding earnings expectations by $0.01 but falling short on revenue, according to the latest report.
For the third quarter, ICL Israel Chemicals reported earnings per share (EPS) of $0.110, surpassing the analyst consensus of $0.098. However, the revenue for the same period came in at $1.86 billion, which fell short of the consensus estimate of $1.89 billion.
ICL Israel Chemicals’ stock price closed at $4.810 following this announcement. Over the last three months, the company’s stock price has declined by -26.000%, while it has experienced a -40.910% decrease over the past 12 months.
In the 90 days leading up to this report, ICL Israel Chemicals witnessed 0 positive EPS revisions and 2 negative EPS revisions. For a comprehensive analysis of ICL Israel Chemicals’ stock price reactions to earnings, you can refer to the historical data.
InvestingPro assesses ICL Israel Chemicals’ financial health as displaying “great performance.”
For further insights into ICL Israel Chemicals’ recent earnings performance and financials, please refer to the relevant information available.
